WO2012160519A3 - Método diagnostico que determina la agresividad y pronostico del cáncer papilar de tiroides - Google Patents
Método diagnostico que determina la agresividad y pronostico del cáncer papilar de tiroides Download PDFInfo
- Publication number
- WO2012160519A3 WO2012160519A3 PCT/IB2012/052572 IB2012052572W WO2012160519A3 WO 2012160519 A3 WO2012160519 A3 WO 2012160519A3 IB 2012052572 W IB2012052572 W IB 2012052572W WO 2012160519 A3 WO2012160519 A3 WO 2012160519A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thyroid cancer
- papillary thyroid
- diagnostic method
- aggressiveness
- prognosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2561/00—Nucleic acid detection characterised by assay method
- C12Q2561/113—Real time assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención provee un método de diagnóstico que permite diferenciar un CPT benigno de un CPT agresivo en un paciente. El método comprende la medición de la expresión de CCR3 en una muestra de tejido tiroideo obtenida del paciente en estudio. CCR3 puede medirse por si solo o en conjunto con otros marcadores. Otros marcadores que pueden cuantificarse para el diagnóstico de pronóstico de CPT corresponden a los receptores de quimokinas CCR7 y CXCR4 u otro tipo de marcadores distintos de receptores de quimokinas. La cuantificación de CCR3 por si sola o en conjunto con la cuantificación de otros marcadores permite comparar los resultados con los valores estándar de dichos marcadores y así determinar si el tumor analizado corresponde a un tumor de características agresivas o benignas. Específicamente, una sobreexpresión de CCR3 se correlaciona con un tumor con parámetros clínicos de agresividad, tal como invasión de la cápsula y metástasis. La invención también provee se refiere a un kit que permite determinar el pronóstico de un CPT, el cual comprende reactivos que permiten la detección de CCR3 en una muestra de tejido tiroideo e instrucciones de uso. En otra modalidad de la invención, se provee un kit para determinar el pronóstico de CPT, el cual comprende reactivos que permiten la detección de CCR3 y de otros marcadores relacionados al CPT. Otros marcadores que pueden cuantificarse para el diagnóstico de pronóstico de CPT corresponden a los receptores de quimokinas CCR7, CXCR4 y/u otro tipo de marcadores distintos de los receptores de quimokinas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2011001209A CL2011001209A1 (es) | 2011-05-24 | 2011-05-24 | Metodo en vitro para determinar pronostico de un cancer papilar de tiroides que comprende cuantificar, en una muestra, la expresion del receptor de quimiokina ccr3 y donde su sobreexpresion respecto de un valor de referencia indica que el tumor tiene altas probabilidades de invadir la capsula y generar metastasis. |
CL1209-2011 | 2011-05-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012160519A2 WO2012160519A2 (es) | 2012-11-29 |
WO2012160519A3 true WO2012160519A3 (es) | 2013-01-31 |
Family
ID=47217824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2012/052572 WO2012160519A2 (es) | 2011-05-24 | 2012-05-23 | Método diagnostico que determina la agresividad y pronostico del cáncer papilar de tiroides |
Country Status (2)
Country | Link |
---|---|
CL (1) | CL2011001209A1 (es) |
WO (1) | WO2012160519A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022133621A1 (es) | 2020-12-24 | 2022-06-30 | Pontificia Universidad Católica De Chile | Método in vitro para el diagnóstico y predicción de la agresividad de cáncer de tiroides, las posibilidades y tipo de cirugía de precisión para la remoción del tumor en un sujeto; kit; reactivos para conformar dicho kit; uso de los reactivos y uso de marcadores moleculares parte del método |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110104717A1 (en) * | 2008-07-10 | 2011-05-05 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
-
2011
- 2011-05-24 CL CL2011001209A patent/CL2011001209A1/es unknown
-
2012
- 2012-05-23 WO PCT/IB2012/052572 patent/WO2012160519A2/es active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110104717A1 (en) * | 2008-07-10 | 2011-05-05 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
Non-Patent Citations (4)
Title |
---|
G0NZALEZ ET AL.: "Altered Chemokine Receptor Expression in Papillary Thyroid Cancer", THYROID, vol. 19, no. 9, September 2009 (2009-09-01), pages 957 - 965 * |
GONZALEZ ET AL.: "Altered Chemokine Receptor Expression in Papillary Thyroid Cancer", THYROID, vol. 19, no. 9, September 2009 (2009-09-01), pages 957 - 965 * |
YASUOKA ET AL.: "CXCR4 expression in papillary thyroid carcinoma: induction by nitnc oxide and correlation with lymph node metastasis", BMC CANER, vol. 8, 30 September 2008 (2008-09-30), pages 274 - 282 * |
YASUOKA ET AL.: "CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis", BMC CANER, vol. 8, 30 September 2008 (2008-09-30), pages 274 - 282 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012160519A2 (es) | 2012-11-29 |
CL2011001209A1 (es) | 2012-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3862439A3 (en) | Liver cancer detection kit or device, and detection method | |
EP3967769A3 (en) | Lung cancer detection kit or device, and detection method | |
EP3816303A3 (en) | Breast cancer detection kit or device, and method for detecting breast cancer | |
WO2013033609A3 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
EP3816302A3 (en) | Esophageal cancer detection kit or device, and detection method | |
EP3800253A3 (en) | Prostate cancer detection kit or device, and detection method | |
WO2013022786A3 (en) | Microrna biomarkers | |
EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
WO2013084002A3 (en) | Method for detecting nucleosome adducts | |
MX364410B (es) | Metodo para detectar nucleosomas que contienen nucleotidos. | |
EP3757225A3 (en) | Pancreatic cancer detection kit or device, and detection method | |
EP3971299A3 (en) | Colorectal cancer detection kit or device, and detection method | |
EP3654036A3 (en) | Stomach cancer biomarker and detection method | |
EP3955004A3 (en) | Use of fatty acids in methods for detecting cancer | |
EP2659268A4 (en) | Systems and methods for high accuracy analyte measurement | |
WO2013030578A3 (en) | Method for detecting nucleosomes | |
BR112016028944A2 (pt) | kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção | |
WO2013107459A3 (en) | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples | |
WO2013025952A3 (en) | Methods and compositions for the treatment and diagnosis of breast cancer | |
WO2012107841A3 (en) | Micro -rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof | |
WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
GB201014837D0 (en) | Biomarker signatures and uses thereof | |
MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
WO2015059487A3 (en) | Detection of cleavage activity of an enzyme | |
AU2019283856A1 (en) | Non-invasive fetal sex determination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12789393 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12789393 Country of ref document: EP Kind code of ref document: A2 |